KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for LifeMD (LFMD) over the last 14 years, with Q3 2025 value amounting to -$8.7 million.

  • LifeMD's Cash from Financing Activities fell 55884.55% to -$8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.6 million, marking a year-over-year decrease of 22125.42%. This contributed to the annual value of -$4.1 million for FY2024, which is 11415.31% down from last year.
  • LifeMD's Cash from Financing Activities amounted to -$8.7 million in Q3 2025, which was down 55884.55% from -$3.1 million recorded in Q2 2025.
  • Over the past 5 years, LifeMD's Cash from Financing Activities peaked at $39.3 million during Q4 2021, and registered a low of -$8.7 million during Q3 2025.
  • In the last 5 years, LifeMD's Cash from Financing Activities had a median value of -$774063.0 in 2022 and averaged $4.2 million.
  • As far as peak fluctuations go, LifeMD's Cash from Financing Activities skyrocketed by 164915.89% in 2023, and later plummeted by 55884.55% in 2025.
  • Quarter analysis of 5 years shows LifeMD's Cash from Financing Activities stood at $39.3 million in 2021, then plummeted by 95.26% to $1.9 million in 2022, then skyrocketed by 671.21% to $14.4 million in 2023, then tumbled by 106.51% to -$934903.0 in 2024, then plummeted by 830.68% to -$8.7 million in 2025.
  • Its Cash from Financing Activities stands at -$8.7 million for Q3 2025, versus -$3.1 million for Q2 2025 and -$812563.0 for Q1 2025.